Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Benefits and Harms of Complementary and Alternative Medicine Therapies for Initial Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.
Asher GN, Gartlehner G, Gaynes BN, Amick HR, Forneris C, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN. Asher GN, et al. Among authors: pierl cb. J Altern Complement Med. 2017 Dec;23(12):907-919. doi: 10.1089/acm.2016.0261. Epub 2017 Jul 12. J Altern Complement Med. 2017. PMID: 28700248 Review.
Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.
Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN. Amick HR, et al. Among authors: pierl cb. BMJ. 2015 Dec 8;351:h6019. doi: 10.1136/bmj.h6019. BMJ. 2015. PMID: 26645251 Free PMC article. Review.
Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians.
Gartlehner G, Gaynes BN, Amick HR, Asher GN, Morgan LC, Coker-Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN. Gartlehner G, et al. Among authors: pierl cb. Ann Intern Med. 2016 Mar 1;164(5):331-41. doi: 10.7326/M15-1813. Epub 2015 Dec 8. Ann Intern Med. 2016. PMID: 26857743 Free article. Review.
Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder [Internet].
Gartlehner G, Gaynes BN, Amick HR, Asher G, Morgan LC, Coker-Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN. Gartlehner G, et al. Among authors: pierl cb. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Dec. Report No.: 15(16)-EHC031-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Dec. Report No.: 15(16)-EHC031-EF. PMID: 26764438 Free Books & Documents. Review.
Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.
Dünnebier T, Bermejo JL, Haas S, Fischer HP, Pierl CB, Justenhoven C, Brauch H, Baisch C, Gilbert M, Harth V, Spickenheuer A, Rabstein S, Pesch B, Brüning T, Ko YD, Hamann U. Dünnebier T, et al. Among authors: pierl cb. Breast Cancer Res Treat. 2010 May;121(1):185-94. doi: 10.1007/s10549-009-0530-y. Epub 2009 Sep 17. Breast Cancer Res Treat. 2010. PMID: 19760037
Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors.
Justenhoven C, Pierl CB, Haas S, Fischer HP, Hamann U, Baisch C, Harth V, Spickenheuer A, Rabstein S, Vollmert C, Illig T, Pesch B, Brüning T, Dippon J, Ko YD, Brauch H. Justenhoven C, et al. Among authors: pierl cb. Int J Cancer. 2009 May 1;124(9):2077-81. doi: 10.1002/ijc.24198. Int J Cancer. 2009. PMID: 19142864 Free article.
CYP2C19*17 is associated with decreased breast cancer risk.
Justenhoven C, Hamann U, Pierl CB, Baisch C, Harth V, Rabstein S, Spickenheuer A, Pesch B, Brüning T, Winter S, Ko YD, Brauch H. Justenhoven C, et al. Among authors: pierl cb. Breast Cancer Res Treat. 2009 May;115(2):391-6. doi: 10.1007/s10549-008-0076-4. Epub 2008 Jun 3. Breast Cancer Res Treat. 2009. PMID: 18521743
The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.
Justenhoven C, Pierl CB, Haas S, Fischer HP, Baisch C, Hamann U, Harth V, Pesch B, Brüning T, Vollmert C, Illig T, Dippon J, Ko YD, Brauch H. Justenhoven C, et al. Among authors: pierl cb. Breast Cancer Res Treat. 2008 Sep;111(1):171-7. doi: 10.1007/s10549-007-9762-x. Epub 2007 Oct 6. Breast Cancer Res Treat. 2008. PMID: 17922187
13 results